Novartis Cancer Unit Escapes Securities Suit
A California federal judge on Wednesday dismissed a proposed securities class action accusing Novartis AG subsidiary Genoptix Inc.'s executives of feathering their nests with company cash as sales figures tanked, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article